Inventiva S.A.
IVA · XNASCIK 1756594fmd_060J3QTBWFH3HBCETGE41XEW2GManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2025, 12 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 7 | 0 | 4 | 12 | 17 | 9 |
| Research and development | 32 | 34 | 24 | 48 | 60 | 110 | 91 |
| Selling, general and administrative | 6 | 6 | 9 | 12 | 15 | 16 | 18 |
| Operating income | (33) | (30) | (30) | (52) | (57) | (103) | (98) |
| Interest expense | 0 | 0 | 6 | 3 | 2 | 7 | 89 |
| Income tax expense | – | 0 | 0 | 0 | (0) | 1 | 0 |
| Net income | (33) | (30) | (34) | (50) | (54) | (110) | (184) |